UCL Business
@uclb.bsky.social
Our role is to nurture technology from UCL, its collaborators and associated hospitals to market, transforming ideas into enterprise with global impact, whilst bringing revenue back to the university to fund more pioneering work.
Europe wants to lead the way for ease and fairness of IP commercialisation.
Under the EU Startup and Scaleup Strategy, the European Commission is creating a blueprint for licensing, revenue-sharing, & equity participation for academic institutions & inventors.
Our CEO, Anne Lane, contributed
1/
Under the EU Startup and Scaleup Strategy, the European Commission is creating a blueprint for licensing, revenue-sharing, & equity participation for academic institutions & inventors.
Our CEO, Anne Lane, contributed
1/
November 10, 2025 at 11:46 AM
Europe wants to lead the way for ease and fairness of IP commercialisation.
Under the EU Startup and Scaleup Strategy, the European Commission is creating a blueprint for licensing, revenue-sharing, & equity participation for academic institutions & inventors.
Our CEO, Anne Lane, contributed
1/
Under the EU Startup and Scaleup Strategy, the European Commission is creating a blueprint for licensing, revenue-sharing, & equity participation for academic institutions & inventors.
Our CEO, Anne Lane, contributed
1/
The AI revolution in life sciences is already here – and it’s changing the sector.
Our CEO, Anne Lane has written about university spinouts, AI and investment in the UK for One Nucleus, sharing her excitement for the potential of the sector here in Britain...
1/
Our CEO, Anne Lane has written about university spinouts, AI and investment in the UK for One Nucleus, sharing her excitement for the potential of the sector here in Britain...
1/
November 7, 2025 at 10:33 AM
The AI revolution in life sciences is already here – and it’s changing the sector.
Our CEO, Anne Lane has written about university spinouts, AI and investment in the UK for One Nucleus, sharing her excitement for the potential of the sector here in Britain...
1/
Our CEO, Anne Lane has written about university spinouts, AI and investment in the UK for One Nucleus, sharing her excitement for the potential of the sector here in Britain...
1/
Thank you to Professor Stefan Howorka for his insightful contributions at our recent IO Converse session!
Professor Howorka, a pioneer of nanopore technology, shared that his attitude towards research has shifted following his journey to commercialisation in a discussion with Barny Cox.
1/
Professor Howorka, a pioneer of nanopore technology, shared that his attitude towards research has shifted following his journey to commercialisation in a discussion with Barny Cox.
1/
November 4, 2025 at 11:30 AM
Thank you to Professor Stefan Howorka for his insightful contributions at our recent IO Converse session!
Professor Howorka, a pioneer of nanopore technology, shared that his attitude towards research has shifted following his journey to commercialisation in a discussion with Barny Cox.
1/
Professor Howorka, a pioneer of nanopore technology, shared that his attitude towards research has shifted following his journey to commercialisation in a discussion with Barny Cox.
1/
A groundbreaking multiple sclerosis trial, that could offer hope to millions, has begun using Autolus Therapeutics CAR T-cell therapy platform.
Patients with progressive multiple sclerosis (PMS) are receiving 'obe-cel' treatment in this phase 1 trial at UCL Hospitals NHS Foundation Trust.
1/
Patients with progressive multiple sclerosis (PMS) are receiving 'obe-cel' treatment in this phase 1 trial at UCL Hospitals NHS Foundation Trust.
1/
October 28, 2025 at 3:17 PM
A groundbreaking multiple sclerosis trial, that could offer hope to millions, has begun using Autolus Therapeutics CAR T-cell therapy platform.
Patients with progressive multiple sclerosis (PMS) are receiving 'obe-cel' treatment in this phase 1 trial at UCL Hospitals NHS Foundation Trust.
1/
Patients with progressive multiple sclerosis (PMS) are receiving 'obe-cel' treatment in this phase 1 trial at UCL Hospitals NHS Foundation Trust.
1/
UCL and its spinouts are leaders for equity investment, according to the Beauhurst report! 🏆
The analytics company ranked UCL fourth for the number of equity deals secured by spinouts in 2024, and second for equity deal volume.
The analytics company ranked UCL fourth for the number of equity deals secured by spinouts in 2024, and second for equity deal volume.
October 21, 2025 at 1:51 PM
UCL and its spinouts are leaders for equity investment, according to the Beauhurst report! 🏆
The analytics company ranked UCL fourth for the number of equity deals secured by spinouts in 2024, and second for equity deal volume.
The analytics company ranked UCL fourth for the number of equity deals secured by spinouts in 2024, and second for equity deal volume.
Ana said:
> 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲: evaluating ideas, shaping business plans, offering IP or licensing advice
> 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝘀: connecting founders with advisers & collaborators
> 𝗙𝗶𝗻𝗮𝗻𝗰𝗲: helping with grant applications, translational funding, providing PoC funds to test / prototype ideas
and more were vital.
> 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲: evaluating ideas, shaping business plans, offering IP or licensing advice
> 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝘀: connecting founders with advisers & collaborators
> 𝗙𝗶𝗻𝗮𝗻𝗰𝗲: helping with grant applications, translational funding, providing PoC funds to test / prototype ideas
and more were vital.
October 17, 2025 at 8:54 AM
Ana said:
> 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲: evaluating ideas, shaping business plans, offering IP or licensing advice
> 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝘀: connecting founders with advisers & collaborators
> 𝗙𝗶𝗻𝗮𝗻𝗰𝗲: helping with grant applications, translational funding, providing PoC funds to test / prototype ideas
and more were vital.
> 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲: evaluating ideas, shaping business plans, offering IP or licensing advice
> 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝘀: connecting founders with advisers & collaborators
> 𝗙𝗶𝗻𝗮𝗻𝗰𝗲: helping with grant applications, translational funding, providing PoC funds to test / prototype ideas
and more were vital.
How can universities support founders of social ventures? 🤝
This was the topic of discussion at the Bates Wells and London Social Venture (LSV) event on 9th October...
Analia Lemmo, UCLB Senior Business Manager, joined the panel to share how ideas can be turned into impact.
This was the topic of discussion at the Bates Wells and London Social Venture (LSV) event on 9th October...
Analia Lemmo, UCLB Senior Business Manager, joined the panel to share how ideas can be turned into impact.
October 17, 2025 at 8:54 AM
How can universities support founders of social ventures? 🤝
This was the topic of discussion at the Bates Wells and London Social Venture (LSV) event on 9th October...
Analia Lemmo, UCLB Senior Business Manager, joined the panel to share how ideas can be turned into impact.
This was the topic of discussion at the Bates Wells and London Social Venture (LSV) event on 9th October...
Analia Lemmo, UCLB Senior Business Manager, joined the panel to share how ideas can be turned into impact.
What if the next global innovation supercluster wasn’t in Boston or Silicon Valley - but in Euston? 🌍
Our CEO Anne Lane joined leaders from Camden Council, Lendlease, UCL partner hospitals and more for the 'Unlocking Inclusive Growth Through Innovation' breakfast at #Lab25 in Liverpool yesterday.
Our CEO Anne Lane joined leaders from Camden Council, Lendlease, UCL partner hospitals and more for the 'Unlocking Inclusive Growth Through Innovation' breakfast at #Lab25 in Liverpool yesterday.
September 30, 2025 at 8:27 AM
What if the next global innovation supercluster wasn’t in Boston or Silicon Valley - but in Euston? 🌍
Our CEO Anne Lane joined leaders from Camden Council, Lendlease, UCL partner hospitals and more for the 'Unlocking Inclusive Growth Through Innovation' breakfast at #Lab25 in Liverpool yesterday.
Our CEO Anne Lane joined leaders from Camden Council, Lendlease, UCL partner hospitals and more for the 'Unlocking Inclusive Growth Through Innovation' breakfast at #Lab25 in Liverpool yesterday.
🚨IO Converse is back!
Don't miss your chance to hear from @ucl.ac.uk’s Professor Stefan Howorka about his journey from academic research to real-world impact.
Prof. Howorka will discuss his experience working with Oxford Nanopore Technologies, an Oxford spinout, including his pivotal role... 1/
Don't miss your chance to hear from @ucl.ac.uk’s Professor Stefan Howorka about his journey from academic research to real-world impact.
Prof. Howorka will discuss his experience working with Oxford Nanopore Technologies, an Oxford spinout, including his pivotal role... 1/
September 29, 2025 at 12:57 PM
🚨IO Converse is back!
Don't miss your chance to hear from @ucl.ac.uk’s Professor Stefan Howorka about his journey from academic research to real-world impact.
Prof. Howorka will discuss his experience working with Oxford Nanopore Technologies, an Oxford spinout, including his pivotal role... 1/
Don't miss your chance to hear from @ucl.ac.uk’s Professor Stefan Howorka about his journey from academic research to real-world impact.
Prof. Howorka will discuss his experience working with Oxford Nanopore Technologies, an Oxford spinout, including his pivotal role... 1/
... of development of many of our highly successful spinouts across a multitude of disciplines.
Take a look at our stats on PoC funding or find out more about how it's helped UCL spinouts: www.uclb.com/2025/09/23/t...
3/3
Take a look at our stats on PoC funding or find out more about how it's helped UCL spinouts: www.uclb.com/2025/09/23/t...
3/3
September 23, 2025 at 1:55 PM
... of development of many of our highly successful spinouts across a multitude of disciplines.
Take a look at our stats on PoC funding or find out more about how it's helped UCL spinouts: www.uclb.com/2025/09/23/t...
3/3
Take a look at our stats on PoC funding or find out more about how it's helped UCL spinouts: www.uclb.com/2025/09/23/t...
3/3
Both were nominated by UCLB.
PoC funding has been a vital part of the commercialisation landscape at UCL for almost 20 years.
It helps bridge the funding gap between research grants and investment, supporting the early stages...
2/3
PoC funding has been a vital part of the commercialisation landscape at UCL for almost 20 years.
It helps bridge the funding gap between research grants and investment, supporting the early stages...
2/3
September 23, 2025 at 1:55 PM
Both were nominated by UCLB.
PoC funding has been a vital part of the commercialisation landscape at UCL for almost 20 years.
It helps bridge the funding gap between research grants and investment, supporting the early stages...
2/3
PoC funding has been a vital part of the commercialisation landscape at UCL for almost 20 years.
It helps bridge the funding gap between research grants and investment, supporting the early stages...
2/3
Thrilled to announce two @ucl.ac.uk researchers have been awarded Proof of Concept funding by @ukri.org.
Max Besenhard's smart chromatography for sustainable drug analysis and purification has been recognised, as has Youngjun Cho's accessible journey planner for disabled people, AI Mapper+.
1/3
Max Besenhard's smart chromatography for sustainable drug analysis and purification has been recognised, as has Youngjun Cho's accessible journey planner for disabled people, AI Mapper+.
1/3
September 23, 2025 at 1:55 PM
Thrilled to announce two @ucl.ac.uk researchers have been awarded Proof of Concept funding by @ukri.org.
Max Besenhard's smart chromatography for sustainable drug analysis and purification has been recognised, as has Youngjun Cho's accessible journey planner for disabled people, AI Mapper+.
1/3
Max Besenhard's smart chromatography for sustainable drug analysis and purification has been recognised, as has Youngjun Cho's accessible journey planner for disabled people, AI Mapper+.
1/3
The IO Inspire Autumn Programme begins next month! ⌛
IO Inspire is a free weekly lunchtime programme for UCL academics looking to explore the commercial potential of their research.
Find out more and register for the programme here:
www.eventbrite.co.uk/e/io-inspire...
IO Inspire is a free weekly lunchtime programme for UCL academics looking to explore the commercial potential of their research.
Find out more and register for the programme here:
www.eventbrite.co.uk/e/io-inspire...
September 19, 2025 at 9:30 AM
The IO Inspire Autumn Programme begins next month! ⌛
IO Inspire is a free weekly lunchtime programme for UCL academics looking to explore the commercial potential of their research.
Find out more and register for the programme here:
www.eventbrite.co.uk/e/io-inspire...
IO Inspire is a free weekly lunchtime programme for UCL academics looking to explore the commercial potential of their research.
Find out more and register for the programme here:
www.eventbrite.co.uk/e/io-inspire...
This Stand Up To Cancer Day, we highlight the latest groundbreaking work in oncology by UCLB’s spinouts, licences and partnerships.
You can read our Stand Up To Cancer Day news story here: www.uclb.com/2025/09/12/s...
You can read our Stand Up To Cancer Day news story here: www.uclb.com/2025/09/12/s...
September 12, 2025 at 3:23 PM
This Stand Up To Cancer Day, we highlight the latest groundbreaking work in oncology by UCLB’s spinouts, licences and partnerships.
You can read our Stand Up To Cancer Day news story here: www.uclb.com/2025/09/12/s...
You can read our Stand Up To Cancer Day news story here: www.uclb.com/2025/09/12/s...
IO Inspire is a free weekly lunchtime programme for UCL academics looking to explore the commercial potential of their research.
The Autumn intake will run from 𝟴𝘁𝗵 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 – 𝟯𝗿𝗱 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿.
Find out more about the programme and how to register here: www.uclb.com/events/io-in...
The Autumn intake will run from 𝟴𝘁𝗵 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 – 𝟯𝗿𝗱 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿.
Find out more about the programme and how to register here: www.uclb.com/events/io-in...
September 5, 2025 at 10:31 AM
IO Inspire is a free weekly lunchtime programme for UCL academics looking to explore the commercial potential of their research.
The Autumn intake will run from 𝟴𝘁𝗵 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 – 𝟯𝗿𝗱 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿.
Find out more about the programme and how to register here: www.uclb.com/events/io-in...
The Autumn intake will run from 𝟴𝘁𝗵 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 – 𝟯𝗿𝗱 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿.
Find out more about the programme and how to register here: www.uclb.com/events/io-in...
Thank you to those who joined us yesterday for another great IO Converse session, hosted by UCLB Senior Business Manager Dr. Caitriona O'Rourke.
We were so pleased to be joined by Dr. Tomas Baldwin, CEO & Co-Founder of UCL spinout Guilford Street Laboratories (GSL).
We were so pleased to be joined by Dr. Tomas Baldwin, CEO & Co-Founder of UCL spinout Guilford Street Laboratories (GSL).
July 3, 2025 at 5:25 PM
Thank you to those who joined us yesterday for another great IO Converse session, hosted by UCLB Senior Business Manager Dr. Caitriona O'Rourke.
We were so pleased to be joined by Dr. Tomas Baldwin, CEO & Co-Founder of UCL spinout Guilford Street Laboratories (GSL).
We were so pleased to be joined by Dr. Tomas Baldwin, CEO & Co-Founder of UCL spinout Guilford Street Laboratories (GSL).
Don't forget to take a look at our newsletter 𝙐𝘾𝙇𝘽 𝙄𝙢𝙥𝙖𝙘𝙩 𝙄𝙣𝙨𝙞𝙜𝙝𝙩𝙨 - a monthly roundup featuring the inspiring stories of success to emerge from commercialising UCL’s world class research.
Read June’s UCLB Impact Insights here: www.linkedin.com/newsletters/...
Read June’s UCLB Impact Insights here: www.linkedin.com/newsletters/...
July 2, 2025 at 8:32 AM
Don't forget to take a look at our newsletter 𝙐𝘾𝙇𝘽 𝙄𝙢𝙥𝙖𝙘𝙩 𝙄𝙣𝙨𝙞𝙜𝙝𝙩𝙨 - a monthly roundup featuring the inspiring stories of success to emerge from commercialising UCL’s world class research.
Read June’s UCLB Impact Insights here: www.linkedin.com/newsletters/...
Read June’s UCLB Impact Insights here: www.linkedin.com/newsletters/...
We caught up with UCLB Associate Director of Biopharm, Mark Fisher ahead of his upcoming webinar, ‘Commercialising your research: a guide for clinicians bringing innovation to the market’.
Find out more and register here: www.uclb.com/events/webin...
Find out more and register here: www.uclb.com/events/webin...
June 17, 2025 at 3:25 PM
We caught up with UCLB Associate Director of Biopharm, Mark Fisher ahead of his upcoming webinar, ‘Commercialising your research: a guide for clinicians bringing innovation to the market’.
Find out more and register here: www.uclb.com/events/webin...
Find out more and register here: www.uclb.com/events/webin...
Our next IO Converse session is on Wednesday 2 July!
We'll be joined by Professor Kevin Mills and Dr. Tomas Baldwin from Guilford Street Laboratories (GSL) to hear about GSL’s mission to elevate care for patients with rare, cardiac and neurodegenerative diseases.
More: www.uclb.com/events/io-co...
We'll be joined by Professor Kevin Mills and Dr. Tomas Baldwin from Guilford Street Laboratories (GSL) to hear about GSL’s mission to elevate care for patients with rare, cardiac and neurodegenerative diseases.
More: www.uclb.com/events/io-co...
June 5, 2025 at 3:29 PM
Our next IO Converse session is on Wednesday 2 July!
We'll be joined by Professor Kevin Mills and Dr. Tomas Baldwin from Guilford Street Laboratories (GSL) to hear about GSL’s mission to elevate care for patients with rare, cardiac and neurodegenerative diseases.
More: www.uclb.com/events/io-co...
We'll be joined by Professor Kevin Mills and Dr. Tomas Baldwin from Guilford Street Laboratories (GSL) to hear about GSL’s mission to elevate care for patients with rare, cardiac and neurodegenerative diseases.
More: www.uclb.com/events/io-co...
Thank you to those who joined us on Wednesday for another great IO Converse session!
We were so pleased to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, who shared her inspiring story from PhD to CEO.
Find out more about IO Converse here: www.uclb.com/ideas-to-opp...
We were so pleased to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, who shared her inspiring story from PhD to CEO.
Find out more about IO Converse here: www.uclb.com/ideas-to-opp...
May 16, 2025 at 11:20 AM
Thank you to those who joined us on Wednesday for another great IO Converse session!
We were so pleased to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, who shared her inspiring story from PhD to CEO.
Find out more about IO Converse here: www.uclb.com/ideas-to-opp...
We were so pleased to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, who shared her inspiring story from PhD to CEO.
Find out more about IO Converse here: www.uclb.com/ideas-to-opp...
UCL academics!
Don't miss our next IO Converse session on Wednesday 14 May. We're delighted to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, an AI medical imaging spinout from UCL and Imperial College London.
More about the event: www.eventbrite.co.uk/e/io-convers...
Don't miss our next IO Converse session on Wednesday 14 May. We're delighted to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, an AI medical imaging spinout from UCL and Imperial College London.
More about the event: www.eventbrite.co.uk/e/io-convers...
May 8, 2025 at 12:53 PM
UCL academics!
Don't miss our next IO Converse session on Wednesday 14 May. We're delighted to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, an AI medical imaging spinout from UCL and Imperial College London.
More about the event: www.eventbrite.co.uk/e/io-convers...
Don't miss our next IO Converse session on Wednesday 14 May. We're delighted to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, an AI medical imaging spinout from UCL and Imperial College London.
More about the event: www.eventbrite.co.uk/e/io-convers...
Delighted to launch our IO Inspire Spring programme earlier this week, helping UCL academics develop the commercial potential of their research.
Thank you to everyone that attended the first session.
Learn more: www.uclb.com/2025/05/02/u...
Thank you to everyone that attended the first session.
Learn more: www.uclb.com/2025/05/02/u...
May 2, 2025 at 3:57 PM
Delighted to launch our IO Inspire Spring programme earlier this week, helping UCL academics develop the commercial potential of their research.
Thank you to everyone that attended the first session.
Learn more: www.uclb.com/2025/05/02/u...
Thank you to everyone that attended the first session.
Learn more: www.uclb.com/2025/05/02/u...
We were delighted to attend the UCL Health of the Public Annual Symposium, showcasing some of the brilliant social ventures that we work with here at UCLB.
Discover how our work with them is empowering communities through public health: www.uclb.com/2025/04/30/u...
#SocialVentures
Discover how our work with them is empowering communities through public health: www.uclb.com/2025/04/30/u...
#SocialVentures
April 30, 2025 at 10:14 AM
We were delighted to attend the UCL Health of the Public Annual Symposium, showcasing some of the brilliant social ventures that we work with here at UCLB.
Discover how our work with them is empowering communities through public health: www.uclb.com/2025/04/30/u...
#SocialVentures
Discover how our work with them is empowering communities through public health: www.uclb.com/2025/04/30/u...
#SocialVentures
UCL academics!
Don't miss our next IO Converse session on Wednesday 14 May. We're delighted to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, an AI medical imaging spinout from UCL and Imperial College London.
More about the event: www.eventbrite.co.uk/e/io-convers...
Don't miss our next IO Converse session on Wednesday 14 May. We're delighted to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, an AI medical imaging spinout from UCL and Imperial College London.
More about the event: www.eventbrite.co.uk/e/io-convers...
April 23, 2025 at 12:15 PM
UCL academics!
Don't miss our next IO Converse session on Wednesday 14 May. We're delighted to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, an AI medical imaging spinout from UCL and Imperial College London.
More about the event: www.eventbrite.co.uk/e/io-convers...
Don't miss our next IO Converse session on Wednesday 14 May. We're delighted to be joined by Dr. Maria Leiloglou, CEO and Co-founder of EnAcuity, an AI medical imaging spinout from UCL and Imperial College London.
More about the event: www.eventbrite.co.uk/e/io-convers...
It was fantastic to be in attendance at this year's Festival of Early Stage Researchers (FESR).
The event was a wonderful opportunity for early career researchers at UCL aspiring to bring their research from the lab to real-world impact.
@ucl.ac.uk @ucltro.bsky.social
The event was a wonderful opportunity for early career researchers at UCL aspiring to bring their research from the lab to real-world impact.
@ucl.ac.uk @ucltro.bsky.social
April 3, 2025 at 10:24 AM
It was fantastic to be in attendance at this year's Festival of Early Stage Researchers (FESR).
The event was a wonderful opportunity for early career researchers at UCL aspiring to bring their research from the lab to real-world impact.
@ucl.ac.uk @ucltro.bsky.social
The event was a wonderful opportunity for early career researchers at UCL aspiring to bring their research from the lab to real-world impact.
@ucl.ac.uk @ucltro.bsky.social